Table 1.
Immune activation biomarkers | ≥48 (High-scorers, 10%a) | <48 (Lower-scorers, 90%) | N |
---|---|---|---|
Cytokine or CRP concentration | |||
TNF-α (pg/mL) (median) | 10.95*** | 8.06 | 634 |
IL-1β (pg/mL) (median) | 0.07^ | 0.06 | 636 |
IL-6 (pg/mL) (median) | 0.82** | 0.52 | 649 |
CRP (mg/L) (median) | 5.49** | 1.80 | 496 |
Cytokine response to ex vivo antigen stimulation | |||
TNF-α (pg/mL) | |||
LPS-stimulated (median) | 143 | 149 | 117 |
PHA-stimulated (median) | 62^ | 38 | 121 |
IL-1β (pg/mL) | |||
LPS-stimulated (median) | 540 | 468 | 119 |
PHA-stimulated (median) | 239* | 98 | 123 |
IL-6 (pg/mL) | |||
LPS-stimulated (median) | 3,719* | 2,589 | 118 |
PHA-stimulated (median) | 3,461* | 2,053 | 124 |
Controls | |||
Age (years) (mean±SD) | 55.4^ ± 11.9 | 53.0 ± 10.8 | 649 |
% female | 72*** | 46 | 649 |
BMI (kg/m2) (mean±SD) | 23.5^ ± 3.9 | 24.1 ± 3.3 | 649 |
p≤0.001
p≤0.01
p≤0.05
p≤0.1 (compared to lower-scorers; Mann-Whitney U or χ2 test)
Risk set includes interviewees that provided a morning fasting blood sample (n=649)